This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Max A Mellmer - Innovator in Neurobiology
Introduction
Max A Mellmer is an inventor based in San Diego, CA. He is currently associated with Neurocrine Biosciences, Inc. Although he does not hold any granted patents, his contributions to the field of neurobiology are noteworthy. His work focuses on developing compounds that can antagonize corticotropin-releasing factor (CRF) receptors, which are crucial in treating various diseases.
Latest Patent Applications
Max A Mellmer has submitted a patent application titled "CRF Receptor Antagonists and Methods of Use." This application details compounds that antagonize CRF receptors, particularly CRF receptor 1. The application also discusses related preparations, compositions, and methods for treating diseases and disorders that could benefit from these compounds, such as congenital adrenal hyperplasia (CAH).
Conclusion
Max A Mellmer is a dedicated inventor whose work at Neurocrine Biosciences, Inc. aims to advance the understanding and treatment of neurobiological disorders. His innovative approach to CRF receptor antagonism holds promise for future therapeutic developments.